Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open–Label Vedolizumab Intravenous Therapy

Project: Research

Project Details

StatusActive
Effective start/end date4/11/21 → 7/10/26

Keywords

  • Colitis
  • treatment safety
  • treatment efficacy
  • phase 3 study
  • therapy